Auriga Research Private Limited, one of India’s foremost Contract Research Organisations (CROs), has signed a strategic Memorandum of Understanding (MoU) with the San Francisco Research Institute (SFRI), a leading US-based organisation in healthcare research and innovation.

This landmark collaboration aims to synergise the core competencies of both organisations to strengthen AI-integrated clinical research, streamline regulatory pathways, and fast-track the development and market access of wellness and healthcare products across India, North America, and Africa.

A New Paradigm in Clinical Research and Digital Health

Under the partnership, Auriga Research will lead clinical operations, regulatory compliance, data management, and trial execution within India and Asia. Simultaneously, SFRI will focus on market expansion, client engagement, and regulatory navigation in key markets such as the United States, Japan, Europe, and Africa.

Key focus areas include:

• AI-enhanced clinical trials for improved patient recruitment, monitoring, and real-time analytics
• Joint development of eCRF systems, digital analytics platforms, and compliance tools for global trials
• AI-powered platforms for regulatory and market readiness in wellness and pharmaceutical domains
• Co-development of innovative wellness products and nutraceuticals for cross-border markets
• Regulatory and commercial support for products like SNEC30 and Ningen in Africa and the US

Bridging Global Regulatory and Innovation Ecosystems

The MoU facilitates a framework for both parties to jointly manage regulatory submissions, ensure compliance with agencies such as FDA (USA), EFSA (Europe), and TGA (Australia), and support public health initiatives and product registrations, especially in countries like Nigeria and other emerging markets.

According to Dr. Saurabh Arora, Managing Director of Auriga Research, “This partnership amplifies our global vision for AI-driven clinical research and accessible healthcare solutions. Together with SFRI, we aim to streamline innovation pipelines and unlock new opportunities across diverse geographies while upholding the highest standards in quality, ethics, and compliance.”

Advancing Capacity Building and Knowledge Exchange

In a bid to build global competency in healthcare quality and safety, the two entities will also co-launch joint training programs focused on Good Clinical Practices (GCP), Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and regulatory documentation (GDP). These programs will be delivered through both virtual platforms and on-site workshops.

Dr. John Ademola, CEO of San Francisco Research Institute, emphasised, “We are excited to partner with Auriga in this cross-continental initiative that not only enhances clinical research efficiency through AI, but also nurtures a culture of regulatory excellence and patient-centric innovation.”

Also read: Nova IVF Fertility Launches 100th Centre in Jammu, Strengthening Nationwide Fertility Network

Unlocking Global Funding and Product Development

The MoU also opens avenues for joint grant applications and funded research projects under global health initiatives. The alliance plans to co-develop new formulations and health-tech solutions while engaging with public health agencies and institutional buyers across key markets.

This collaboration reinforces India’s expanding footprint in the global CRO and health-tech export markets while aligning with the international healthcare industry’s growing demand for evidence-based, technology-driven, and regulatory-compliant solutions.

With Auriga’s regional strength and SFRI’s global influence, this partnership is poised to become a model of cross-border collaboration in digital health, AI-enabled research, and wellness innovation.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!